Adicet Bio Grants Inducement Stock Options to New Hire Under 2022 Inducement Plan
Reuters
Oct 01
Adicet Bio Grants Inducement Stock Options to New Hire Under 2022 Inducement Plan
Adicet Bio Inc. has announced the grant of a new hire inducement award to an employee who joined the company in September 2025. The award consists of non-qualified stock options to purchase 9,800 shares of Adicet's common stock at an exercise price of $0.81 per share, the closing price on September 30, 2025. Under the terms of the agreement, one-fourth of the options will vest on the employee's one-year anniversary, with the remaining options vesting in equal monthly installments over the following three years, becoming fully vested on the fourth anniversary of the employee's start date.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adicet Bio Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250930384329) on September 30, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.